Antibiotic Use and Presumptive Pathogens in the Veterans Affairs Healthcare System.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
07 01 2022
Historique:
received: 23 11 2020
pubmed: 24 2 2021
medline: 15 3 2022
entrez: 23 2 2021
Statut: ppublish

Résumé

Empirical antibiotic use is common in the hospital. Here, we characterize patterns of antibiotic use, infectious diagnoses, and microbiological laboratory results among hospitalized patients and aim to quantify the proportion of antibiotic use that is potentially attributable to specific bacterial pathogens. We conducted an observational study using electronic health records from acute care facilities in the US Veterans Affairs Healthcare System. From October 2017 to September 2018, 482 381 hospitalizations for 332 657 unique patients that met all criteria were included. At least 1 antibiotic was administered at 202 037 (41.9%) of included hospital stays. We measured frequency of antibiotic use, microbiological specimen collection, and bacterial isolation by diagnosis category and antibiotic group. A tiered system based on specimen collection sites and diagnoses was used to attribute antibiotic use to presumptive causative organisms. Specimens were collected at 130 012 (64.4%) hospitalizations with any antibiotic use, and at least 1 bacterial organism was isolated at 35.1% of these stays. Frequency of bacterial isolation varied widely by diagnosis category and antibiotic group. Under increasingly lenient criteria, 10.2%-31.4% of 974 733 antibiotic days of therapy could be linked to a potential bacterial pathogen. Overall, the vast majority of antibiotic use could be linked to either an infectious diagnosis or microbiological specimen. Nearly one-half of antibiotic use occurred when there was a specimen collected but no bacterial organism identified, underscoring the need for rapid and improved diagnostics to optimize antibiotic use.

Sections du résumé

BACKGROUND
Empirical antibiotic use is common in the hospital. Here, we characterize patterns of antibiotic use, infectious diagnoses, and microbiological laboratory results among hospitalized patients and aim to quantify the proportion of antibiotic use that is potentially attributable to specific bacterial pathogens.
METHODS
We conducted an observational study using electronic health records from acute care facilities in the US Veterans Affairs Healthcare System. From October 2017 to September 2018, 482 381 hospitalizations for 332 657 unique patients that met all criteria were included. At least 1 antibiotic was administered at 202 037 (41.9%) of included hospital stays. We measured frequency of antibiotic use, microbiological specimen collection, and bacterial isolation by diagnosis category and antibiotic group. A tiered system based on specimen collection sites and diagnoses was used to attribute antibiotic use to presumptive causative organisms.
RESULTS
Specimens were collected at 130 012 (64.4%) hospitalizations with any antibiotic use, and at least 1 bacterial organism was isolated at 35.1% of these stays. Frequency of bacterial isolation varied widely by diagnosis category and antibiotic group. Under increasingly lenient criteria, 10.2%-31.4% of 974 733 antibiotic days of therapy could be linked to a potential bacterial pathogen.
CONCLUSIONS
Overall, the vast majority of antibiotic use could be linked to either an infectious diagnosis or microbiological specimen. Nearly one-half of antibiotic use occurred when there was a specimen collected but no bacterial organism identified, underscoring the need for rapid and improved diagnostics to optimize antibiotic use.

Identifiants

pubmed: 33621326
pii: 6148740
doi: 10.1093/cid/ciab170
pmc: PMC8752245
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

105-112

Subventions

Organisme : ACL HHS
ID : U01CK000538
Pays : United States
Organisme : NIH HHS
Pays : United States
Organisme : CDC HHS
ID : CK000538-01
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007535
Pays : United States
Organisme : Department of Veterans Affairs, Veterans Health Administration
Organisme : NCEZID CDC HHS
ID : U01 CK000538
Pays : United States

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Références

Scand J Infect Dis. 2002;34(1):56-60
pubmed: 11874166
Intern Med J. 2012 Jun;42(6):719-21
pubmed: 22697156
J Clin Microbiol. 2003 Jun;41(6):2275-8
pubmed: 12791835
JAMA. 2014 Oct 8;312(14):1438-46
pubmed: 25291579
Clin Microbiol Infect. 2016 Oct;22(10):888.e1-888.e9
pubmed: 27432770
BMC Infect Dis. 2011 Jul 05;11:187
pubmed: 21729289
J Clin Epidemiol. 2007 Apr;60(4):397-409
pubmed: 17346615
J Clin Microbiol. 2020 Apr 23;58(5):
pubmed: 32051261
Clin Infect Dis. 2018 Jul 2;67(2):179-185
pubmed: 29409000
Clin Infect Dis. 2002 Mar 1;34(5):634-40
pubmed: 11823954
Eur J Clin Microbiol Infect Dis. 2006 Oct;25(10):615-7
pubmed: 16896821
Clin Microbiol Infect. 2000 Feb;6(2):99-102
pubmed: 11168080
Chest. 1992 Apr;101(4):1005-12
pubmed: 1555415
Arch Intern Med. 2000 Nov 27;160(21):3252-7
pubmed: 11088086
Clin Microbiol Rev. 2009 Oct;22(4):582-610
pubmed: 19822890
Arch Intern Med. 2003 Apr 28;163(8):972-8
pubmed: 12719208
Arthritis Care Res (Hoboken). 2013 Aug;65(8):1343-57
pubmed: 23335588
Diagn Microbiol Infect Dis. 2013 May;76(1):24-30
pubmed: 23537783
Am J Transplant. 2016 Jul;16(7):2224-30
pubmed: 27348802
Lancet. 1981 Aug 15;2(8242):349-52
pubmed: 6115119
BMJ. 2019 Jan 16;364:k5092
pubmed: 30651273
Clin Infect Dis. 2007 Jan 15;44(2):159-77
pubmed: 17173212
Clin Infect Dis. 1999 Jul;29(1):60-6; discussion 67-8
pubmed: 10433566
Lancet Infect Dis. 2014 Dec;14(12):1220-7
pubmed: 25455989
J Antimicrob Chemother. 2016 Feb;71(2):539-46
pubmed: 26538501
Int J Antimicrob Agents. 2004 Apr;23(4):325-31
pubmed: 15081079
Clin Infect Dis. 2014 Mar;58(5):688-96
pubmed: 24218103
Clin Infect Dis. 2015 Nov 1;61(9):1403-10
pubmed: 26223995
Pneumonia (Nathan). 2016 Apr 12;8:1
pubmed: 28702281

Auteurs

Christine Tedijanto (C)

Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, Massachusetts, USA.

McKenna Nevers (M)

Division of Epidemiology, University of Utah, Salt Lake City, Utah, USA.

Matthew H Samore (MH)

Division of Epidemiology, University of Utah, Salt Lake City, Utah, USA.

Marc Lipsitch (M)

Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, Massachusetts, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH